The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Hydroxy-N-[(3,5-difluoro-4'-(trifluoromethyl))biphenyl-4-yl]-1,2,5-oxadiazole-3-carboxamide ID: ALA1946848
PubChem CID: 57381529
Max Phase: Preclinical
Molecular Formula: C16H8F5N3O3
Molecular Weight: 385.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1c(F)cc(-c2ccc(C(F)(F)F)cc2)cc1F)c1nonc1O
Standard InChI: InChI=1S/C16H8F5N3O3/c17-10-5-8(7-1-3-9(4-2-7)16(19,20)21)6-11(18)12(10)22-14(25)13-15(26)24-27-23-13/h1-6H,(H,22,25)(H,24,26)
Standard InChI Key: OGZFCOSJXCOOPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
16.3527 -10.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3516 -10.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0664 -11.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7828 -10.9477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7800 -10.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0646 -9.7080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6368 -11.3601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9226 -10.9470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2079 -11.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9233 -10.1220 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4335 -11.0727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9256 -11.7228 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3869 -12.4068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1799 -12.1793 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2080 -10.2791 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0662 -12.1860 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.6382 -9.7085 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.4898 -9.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2061 -10.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9186 -9.7003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9159 -8.8744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1949 -8.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4854 -8.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6283 -8.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3448 -8.8671 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.6241 -7.6333 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.3375 -8.0375 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
13 14 1 0
14 9 2 0
2 7 1 0
11 15 1 0
3 4 2 0
3 16 1 0
7 8 1 0
1 17 1 0
8 9 1 0
18 19 2 0
4 5 1 0
19 20 1 0
8 10 2 0
20 21 2 0
9 11 1 0
21 22 1 0
2 3 1 0
22 23 2 0
23 18 1 0
5 18 1 0
5 6 2 0
21 24 1 0
6 1 1 0
24 25 1 0
1 2 2 0
24 26 1 0
11 12 2 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.25Molecular Weight (Monoisotopic): 385.0486AlogP: 3.99#Rotatable Bonds: 3Polar Surface Area: 88.25Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.37CX Basic pKa: ┄CX LogP: 4.14CX LogD: 2.28Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.45
References 1. Lolli ML, Giorgis M, Tosco P, Foti A, Fruttero R, Gasco A.. (2012) New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold., 49 [PMID:22245049 ] [10.1016/j.ejmech.2011.12.038 ]